Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Shortages (11)
- (-) Non-prescription medicines (7)
- Alert/Advisory (1067)
- Medicine safety (493)
- Medical devices safety (343)
- Safety (61)
- Regulatory compliance (23)
- Import and export (18)
- Listed medicines (16)
- Prescription medicines (16)
- Over the counter (OTC) medicines (14)
- Therapeutic goods regulation (14)
- Complementary medicines (12)
- Australian Register of Therapeutic Goods (ARTG) (11)
- Blood safety (8)
- Advertising (4)
- Labelling and packaging (3)
- Sunscreens (3)
- Breast implant hub (2)
- Legislation (2)
- Assessed listed medicines (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
- Weight loss products (1)
Search
18 result(s) found, displaying 1 to 18
-
Market actionsBrauer Natural Medicine is recalling several batches of its Baby & Child Teething Gel, 20 g, due to the potential for a small plastic fragment from the tube rim being present in the gel.
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
Medicine shortage alertsThe supply of Ozempic (semaglutide) will continue to be limited until 31 December 2025
-
Medicine shortage alertsPharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
Medicine shortage alertsPharmacists may dispense alternative brands or strengths without a new prescription.
-
Safety alertsThe oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
-
Safety alertsWe have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.
-
Medicine shortage alertsPharmacists can now substitute one Orencia 125 mg product for the other
-
Market actionsKin Fertility Pty Ltd is recalling several batches of The Prenatal capsules due to reported quality problems with the capsules. There is no indication of any safety concerns.
-
Safety alertsThe TGA has received reports of liver problems experienced by consumers taking medicines containing turmeric or curcumin.
-
Safety alertsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
-
Safety alertsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
-
Safety alertsBEWARE - Health supplements containing vitamin B6 can cause peripheral neuropathy
-
Medicine shortage alertsThe shortage of Metalyse (tenecteplase) is now resolved.
-
Medicine shortage alertsAlternative product approved to address expected shortage
-
-
Safety alertsSafety advisory - alternative product filling shortage may cause airway irritation if administered via inhalation